摘要
目的探讨氨溴索联合布地奈德雾化吸入治疗新生儿肺炎的临床效果。方法根据不同的治疗方案将我院收治的108例肺炎新生儿分为对照组与观察组,各54例。对照组仅应用氨溴索治疗,观察组加用布地奈德雾化吸入治疗。比较两组患儿的临床治疗疗效。结果观察组治疗总有效率94.44%,明显高于对照组的79.63%(P<0.05)。观察组患儿的RR、VT、TPEF/TE、VPEF/VE及PEF均显著优于对照组(P<0.05)。观察组肺部啰音消失时间、口唇紫绀消失时间、鼻阻消失时间、气促消失时间及住院时间均明显短于对照组(P<0.05)。结论应用氨溴索联合布地奈德雾化吸入治疗新生儿肺炎,能够更快地改善患儿的临床症状,巩固治疗效果,改善肺功能,具备临床推广价值。
Objective To investigate the clinical effect of ambroxol combined with budesonide atomization inhalation for neonatal pneumonia. Methods＇ A total of 108 cases of neonatal pneumonia in our hospital were divided into control group and observation group according to the different treatment, with 54 cases in each group. The control group was given ambroxol atomization inhalation, the observation group was treated with ambroxol and budesonide atomization inhalation. The clinical efficacy of the two groups was compared. Results＇ The total effective rate of the observation group was 94.44%, which was significantly higher than 79.63% of the control group （P〈0.05）. The levels of RR, VT, TPEF/TE, VPEF/VE and PEF in the observation group were significantly better than those in the control group （P〈0.05）. The disappearance times of lung rale, cyanosis of lips, nasal obstruction and anhelation, hospitalization time in the observation group were significantly shorter than those in the control group （P〈0.05）. Conclusion Ambroxol combined with budesonide inhalation treatment in the treatment of neonatal pneumonia can improve the clinical symptoms of children, improve their lung function indicators, consolidate the therapeutic effect, which has the value of clinical promotion.
作者
赵红莉
ZHAO Hong-li(Maternal and Child Health Care Hospital of Mei County, Baoji 722300, Chin)
出处
《临床医学研究与实践》
2018年第13期79-80,共2页
Clinical Research and Practice
关键词
新生儿肺炎
氨溴索
布地奈德
雾化吸入
neonatal pneumonia
ambroxol
budesonide
atomization inhalation
作者简介
赵红莉（1976-），女，汉族，陕西眉县人，主治医师，学士。研究方向：儿科。
